Your browser doesn't support javascript.
loading
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.
Mahanta, Saurov; Chowdhury, Purvita; Gogoi, Neelutpal; Goswami, Nabajyoti; Borah, Debajit; Kumar, Rupesh; Chetia, Dipak; Borah, Probodh; Buragohain, Alak K; Gogoi, Bhaskarjyoti.
Afiliación
  • Mahanta S; National Institute of Electronics and Information Technology (NIELIT), Guwahati, Guwahati, Assam, India.
  • Chowdhury P; Model Rural Health Research Unit (MRHRU), Tripura, India.
  • Gogoi N; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
  • Goswami N; Bioinformatics Infrastructure Facility, College of Veterinary Science, Assam Agricultural University, Guwahati, India.
  • Borah D; Department of Biotechnology, Royal Global University, Guwahati, India.
  • Kumar R; Department of Biotechnology, Royal Global University, Guwahati, India.
  • Chetia D; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
  • Borah P; Bioinformatics Infrastructure Facility, College of Veterinary Science, Assam Agricultural University, Guwahati, India.
  • Buragohain AK; Department of Biotechnology, Royal Global University, Guwahati, India.
  • Gogoi B; Department of Biotechnology, Royal Global University, Guwahati, India.
J Biomol Struct Dyn ; 39(10): 3802-3811, 2021 07.
Article en En | MEDLINE | ID: mdl-32406317
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_geracao_evidencia_conhecimento / 4_covid_19 Asunto principal: Antivirales / Inhibidores de Proteasas / Proteasas 3C de Coronavirus / SARS-CoV-2 Idioma: En Revista: J Biomol Struct Dyn Año: 2021 Tipo del documento: Article País de afiliación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_geracao_evidencia_conhecimento / 4_covid_19 Asunto principal: Antivirales / Inhibidores de Proteasas / Proteasas 3C de Coronavirus / SARS-CoV-2 Idioma: En Revista: J Biomol Struct Dyn Año: 2021 Tipo del documento: Article País de afiliación: India